|Videos|October 19, 2021
Patient Case #2 Continued: Novel Second-Generation Antipsychotics
A panel of experts in psychiatry consider the use of a novel second-generation antipsychotic for the management of treatment resistant depression.
Advertisement
Episodes in this series
Advertisement
Related to this article
Andrew A. Nierenberg, MD, explains how a learning health network helps clinicians measure outcomes and redesign bipolar disorder care together with patients.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The New, Impending Adult ADHD Guidelines
2
Two New MDD Approvals: 5-HT1A Agonism and Adjunctive Atypical Antipsychotics
3
Olanzapine LAI (Weltruza) Receives FDA Approval for Schizophrenia
4
What Makes Us Human? The Role of Psychiatry and the Future DSM
5